EDIT:NASDAQ
Editas Medicine Inc
US$ 2.17
arrow_upward
+1.40%(+0.030) Siku 1
13 Nov, 16:00:01 GMT -5 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya EDIT...
Fungua
US$ 2.14
Juu
US$ 2.21
Chini
US$ 2.01
Mtaji wa soko
334.92M
Wastani wa kiasi cha mauzo
2.42M
Kiasi cha mauzo ya hisa
2.79M
Juu kwa wiki 52
US$ 3.94
Chini kwa wiki 52
US$ 1.66
EPS
-US$ 0.62
Beta
2.09
Hisa za wawekezaji
154.34M
Idadi ya wafanyakazi
87
Fungua
US$ 2.14
Juu
US$ 2.21
Chini
US$ 2.01
Mtaji wa soko
334.92M
Wastani wa kiasi cha mauzo
2.42M
Kiasi cha mauzo ya hisa
2.79M
Juu kwa wiki 52
US$ 3.94
Chini kwa wiki 52
US$ 1.66
EPS
-US$ 0.62
Beta
2.09
Hisa za wawekezaji
154.34M
Idadi ya wafanyakazi
87
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
TradingView
·
saa 6 zilizopita
EXCLUSIVE: S&P 500’s Sell-Off Tested Buffered ETFs: Expert Explains Why a 10% Buffer May Not Protect You as Expected
24/7 Wall St.
·
saa 2 zilizopita
He Thinks His $200,000 S&P 500 401(k) Spreads His AI Risk. Two Alphabet Share Classes Put $10,380 in One Company. A 20% Drop Could Cost Him $2,076
Bloomberg.com
·
saa 11 zilizopita
SpaceX’s S&P 500 Bid Gets New Life as Musk Pitches Tesla Merger
Traders Union
·
saa 6 zilizopita
Michael Kantro: Institutional investors focus on stock picking as S&P 500 targets have lost relevance
Wasifu
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
Kuhusu Editas Medicine Inc
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazi87
LilianzishwaNov 2013
Makao makuu-
SektaHealth Care
Sekta-
Tovutieditasmedicine.com